Table 1.
n | % | ||
---|---|---|---|
Total Subjects Studied | 240 | ||
Subjects Included | 155 | ||
Clinical Characteristics | |||
Male | 80 | 52% | |
Female | 75 | 48% | |
Age at implant 18–29 | 7 | 4% | |
Age at implant 30–64 | 75 | 48% | |
Age at implant >64 | 75 | 48% | |
Device Implanted | |||
Clarion HiRes 90K | 23 | 15% | |
Clarion HiRes 90K Mid-Scala | 12 | 8% | |
Clarion HiRes 90K with Helix | 3 | 2% | |
Med-El Concert Flex 24 | 2 | 1% | |
Med-El Concert Flex 28 | 1 | 1% | |
Med-El Synchrony Flex 28 | 1 | 1% | |
Med-El Synchrony Standard | 1 | 1% | |
Nucleus CI 24RE(CA) | 17 | 11% | |
Nucleus CI422 | 45 | 29% | |
Nucleus CI512(CA) | 15 | 10% | |
Nucleus CI512 (profile) | 3 | 2% | |
Nucleus Hybrid S8 (24M) | 3 | 2% | |
Nucleus Hybrid S8 (24RE) | 3 | 2% | |
Nucleus Hybrid L24 | 20 | 13% | |
Nucleus Hybrid S12 | 6 | 4% | |
Analysis Group | |||
Neural - Genetic | 24 | 16% | |
Sensory - Genetic | 12 | 8% | |
Bilateral SSNHL | 13 | 8% | |
Ménière’s Disease | 6 | 4% | |
Otosclerosis | 5 | 3% | |
Single sided deafness | 26 | 17% | |
Other | 10 | 6% | |
Unknown | 60 | 38% |